Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Large Diversity and Original Structures of Acyl-Homoserine Lactones in Strain MOLA 401, a Marine Rhodobacteraceae Bacterium.

Doberva M, Stien D, Sorres J, Hue N, Sanchez-Ferandin S, Eparvier V, Ferandin Y, Lebaron P, Lami R.

Front Microbiol. 2017 Jun 22;8:1152. doi: 10.3389/fmicb.2017.01152. eCollection 2017.

2.

Genome Sequence of the Sponge-Associated Ruegeria halocynthiae Strain MOLA R1/13b, a Marine Roseobacter with Two Quorum-Sensing-Based Communication Systems.

Doberva M, Sanchez-Ferandin S, Ferandin Y, Intertaglia L, Croué J, Suzuki M, Lebaron P, Lami R.

Genome Announc. 2014 Oct 9;2(5). pii: e00998-14. doi: 10.1128/genomeA.00998-14.

3.

Genome Sequence of Maribius sp. Strain MOLA 401, a Marine Roseobacter with a Quorum-Sensing Cell-Dependent Physiology.

Doberva M, Sanchez-Ferandin S, Ferandin Y, Intertaglia L, Joux F, Lebaron P, Lami R.

Genome Announc. 2014 Oct 2;2(5). pii: e00997-14. doi: 10.1128/genomeA.00997-14.

4.

CDK10/cyclin M is a protein kinase that controls ETS2 degradation and is deficient in STAR syndrome.

Guen VJ, Gamble C, Flajolet M, Unger S, Thollet A, Ferandin Y, Superti-Furga A, Cohen PA, Meijer L, Colas P.

Proc Natl Acad Sci U S A. 2013 Nov 26;110(48):19525-30. doi: 10.1073/pnas.1306814110. Epub 2013 Nov 11.

5.

Novel Inverse Binding Mode of Indirubin Derivatives Yields Improved Selectivity for DYRK Kinases.

Myrianthopoulos V, Kritsanida M, Gaboriaud-Kolar N, Magiatis P, Ferandin Y, Durieu E, Lozach O, Cappel D, Soundararajan M, Filippakopoulos P, Sherman W, Knapp S, Meijer L, Mikros E, Skaltsounis AL.

ACS Med Chem Lett. 2013 Jan 10;4(1):22-26. Epub 2012 Nov 1.

6.

Potent inhibitors of CDK5 derived from roscovitine: synthesis, biological evaluation and molecular modelling.

Demange L, Abdellah FN, Lozach O, Ferandin Y, Gresh N, Meijer L, Galons H.

Bioorg Med Chem Lett. 2013 Jan 1;23(1):125-31. doi: 10.1016/j.bmcl.2012.10.141. Epub 2012 Nov 10.

PMID:
23218601
7.

First BRET-based screening assay performed in budding yeast leads to the discovery of CDK5/p25 interaction inhibitors.

Corbel C, Wang Q, Bousserouel H, Hamdi A, Zhang B, Lozach O, Ferandin Y, Tan VB, Guéritte F, Colas P, Couturier C, Bach S.

Biotechnol J. 2011 Jul;6(7):860-70. doi: 10.1002/biot.201100138. Epub 2011 Jun 16.

PMID:
21681968
8.

Synthesis, protein kinase inhibitory potencies, and in vitro antiproliferative activities of meridianin derivatives.

Giraud F, Alves G, Debiton E, Nauton L, Théry V, Durieu E, Ferandin Y, Lozach O, Meijer L, Anizon F, Pereira E, Moreau P.

J Med Chem. 2011 Jul 14;54(13):4474-89. doi: 10.1021/jm200464w. Epub 2011 Jun 10.

PMID:
21623630
9.

Design, synthesis, and testing of an 6-O-linked series of benzimidazole based inhibitors of CDK5/p25.

Jain P, Flaherty PT, Yi S, Chopra I, Bleasdell G, Lipay J, Ferandin Y, Meijer L, Madura JD.

Bioorg Med Chem. 2011 Jan 1;19(1):359-73. doi: 10.1016/j.bmc.2010.11.022. Epub 2010 Dec 6.

PMID:
21144757
10.

Development of 5-benzylpaullones and paullone-9-carboxylic acid alkyl esters as selective inhibitors of mitochondrial malate dehydrogenase (mMDH).

Becker A, Kohfeld S, Lader A, Preu L, Pies T, Wieking K, Ferandin Y, Knockaert M, Meijer L, Kunick C.

Eur J Med Chem. 2010 Jan;45(1):335-42. doi: 10.1016/j.ejmech.2009.10.018. Epub 2009 Oct 14.

PMID:
19906467
11.

Synthesis and kinase inhibitory activity of novel substituted indigoids.

Beauchard A, Laborie H, Rouillard H, Lozach O, Ferandin Y, Le Guével R, Guguen-Guillouzo C, Meijer L, Besson T, Thiéry V.

Bioorg Med Chem. 2009 Sep 1;17(17):6257-63. doi: 10.1016/j.bmc.2009.07.051. Epub 2009 Jul 25.

PMID:
19665384
12.

Synthesis and biological activities of aminopyrimidyl-indoles structurally related to meridianins.

Akue-Gedu R, Debiton E, Ferandin Y, Meijer L, Prudhomme M, Anizon F, Moreau P.

Bioorg Med Chem. 2009 Jul 1;17(13):4420-4. doi: 10.1016/j.bmc.2009.05.017. Epub 2009 May 12.

PMID:
19477650
13.

Anticancer alkaloid lamellarins inhibit protein kinases.

Baunbaek D, Trinkler N, Ferandin Y, Lozach O, Ploypradith P, Rucirawat S, Ishibashi F, Iwao M, Meijer L.

Mar Drugs. 2008;6(4):514-27. doi: 10.3390/md20080026. Epub 2008 Oct 7.

14.

Pyrazolo[1,5-a]-1,3,5-triazine as a purine bioisostere: access to potent cyclin-dependent kinase inhibitor (R)-roscovitine analogue.

Popowycz F, Fournet G, Schneider C, Bettayeb K, Ferandin Y, Lamigeon C, Tirado OM, Mateo-Lozano S, Notario V, Colas P, Bernard P, Meijer L, Joseph B.

J Med Chem. 2009 Feb 12;52(3):655-63. doi: 10.1021/jm801340z.

15.

Soluble 3',6-substituted indirubins with enhanced selectivity toward glycogen synthase kinase -3 alter circadian period.

Vougogiannopoulou K, Ferandin Y, Bettayeb K, Myrianthopoulos V, Lozach O, Fan Y, Johnson CH, Magiatis P, Skaltsounis AL, Mikros E, Meijer L.

J Med Chem. 2008 Oct 23;51(20):6421-31. doi: 10.1021/jm800648y. Epub 2008 Sep 25.

16.

N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitine.

Bettayeb K, Sallam H, Ferandin Y, Popowycz F, Fournet G, Hassan M, Echalier A, Bernard P, Endicott J, Joseph B, Meijer L.

Mol Cancer Ther. 2008 Sep;7(9):2713-24. doi: 10.1158/1535-7163.MCT-08-0080.

17.

Roscovitine-derived, dual-specificity inhibitors of cyclin-dependent kinases and casein kinases 1.

Oumata N, Bettayeb K, Ferandin Y, Demange L, Lopez-Giral A, Goddard ML, Myrianthopoulos V, Mikros E, Flajolet M, Greengard P, Meijer L, Galons H.

J Med Chem. 2008 Sep 11;51(17):5229-42. doi: 10.1021/jm800109e. Epub 2008 Aug 13.

PMID:
18698753
18.

CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases.

Bettayeb K, Oumata N, Echalier A, Ferandin Y, Endicott JA, Galons H, Meijer L.

Oncogene. 2008 Oct 2;27(44):5797-807. doi: 10.1038/onc.2008.191. Epub 2008 Jun 23.

PMID:
18574471
19.

Photoreactivity of indirubin derivatives.

Olivier D, Poincelot MA, Douillard S, Lefevre C, Moureau J, Ferandin Y, Bettayeb K, Xiao Z, Magiatis P, Skaltsounis L, Meijer L, Patrice T.

Photochem Photobiol Sci. 2008 Mar;7(3):328-36. doi: 10.1039/b711261k. Epub 2008 Jan 22.

PMID:
18389150
20.

9-cyano-1-azapaullone (cazpaullone), a glycogen synthase kinase-3 (GSK-3) inhibitor activating pancreatic beta cell protection and replication.

Stukenbrock H, Mussmann R, Geese M, Ferandin Y, Lozach O, Lemcke T, Kegel S, Lomow A, Burk U, Dohrmann C, Meijer L, Austen M, Kunick C.

J Med Chem. 2008 Apr 10;51(7):2196-207. doi: 10.1021/jm701582f. Epub 2008 Mar 18.

PMID:
18345612
21.

Meriolins (3-(pyrimidin-4-yl)-7-azaindoles): synthesis, kinase inhibitory activity, cellular effects, and structure of a CDK2/cyclin A/meriolin complex.

Echalier A, Bettayeb K, Ferandin Y, Lozach O, Clément M, Valette A, Liger F, Marquet B, Morris JC, Endicott JA, Joseph B, Meijer L.

J Med Chem. 2008 Feb 28;51(4):737-51. doi: 10.1021/jm700940h. Epub 2008 Jan 31.

PMID:
18232649
22.

Meriolins, a new class of cell death inducing kinase inhibitors with enhanced selectivity for cyclin-dependent kinases.

Bettayeb K, Tirado OM, Marionneau-Lambot S, Ferandin Y, Lozach O, Morris JC, Mateo-Lozano S, Drueckes P, Schächtele C, Kubbutat MH, Liger F, Marquet B, Joseph B, Echalier A, Endicott JA, Notario V, Meijer L.

Cancer Res. 2007 Sep 1;67(17):8325-34.

23.

An integrated computational approach to the phenomenon of potent and selective inhibition of aurora kinases B and C by a series of 7-substituted indirubins.

Myrianthopoulos V, Magiatis P, Ferandin Y, Skaltsounis AL, Meijer L, Mikros E.

J Med Chem. 2007 Aug 23;50(17):4027-37. Epub 2007 Aug 1.

PMID:
17665890
24.

Purification of CK1 by affinity chromatography on immobilised axin.

Reinhardt J, Ferandin Y, Meijer L.

Protein Expr Purif. 2007 Jul;54(1):101-9. Epub 2007 Mar 12.

PMID:
17434749
25.

3'-Substituted 7-halogenoindirubins, a new class of cell death inducing agents.

Ferandin Y, Bettayeb K, Kritsanida M, Lozach O, Polychronopoulos P, Magiatis P, Skaltsounis AL, Meijer L.

J Med Chem. 2006 Jul 27;49(15):4638-49.

PMID:
16854069
26.

Synthesis of novel 5-substituted indirubins as protein kinases inhibitors.

Beauchard A, Ferandin Y, Frère S, Lozach O, Blairvacq M, Meijer L, Thiéry V, Besson T.

Bioorg Med Chem. 2006 Sep 15;14(18):6434-43. Epub 2006 Jun 8.

PMID:
16759872
27.

7-Bromoindirubin-3'-oxime induces caspase-independent cell death.

Ribas J, Bettayeb K, Ferandin Y, Knockaert M, Garrofé-Ochoa X, Totzke F, Schächtele C, Mester J, Polychronopoulos P, Magiatis P, Skaltsounis AL, Boix J, Meijer L.

Oncogene. 2006 Oct 12;25(47):6304-18. Epub 2006 May 15.

PMID:
16702956
28.

Modular asymmetric synthesis of aigialomycin D, a kinase-inhibitory scaffold.

Barluenga S, Dakas PY, Ferandin Y, Meijer L, Winssinger N.

Angew Chem Int Ed Engl. 2006 Jun 12;45(24):3951-4. No abstract available.

PMID:
16683294
29.

Crystal structure of pyridoxal kinase in complex with roscovitine and derivatives.

Tang L, Li MH, Cao P, Wang F, Chang WR, Bach S, Reinhardt J, Ferandin Y, Galons H, Wan Y, Gray N, Meijer L, Jiang T, Liang DC.

J Biol Chem. 2005 Sep 2;280(35):31220-9. Epub 2005 Jun 28.

Supplemental Content

Loading ...
Support Center